Indo-Bangla Pharmaceuticals Limited (DSE:IBP)
Bangladesh
· Delayed Price · Currency is BDT 13.00
-0.10 (-0.76%)
At close: Aug 14, 2025
DSE:IBP Balance Sheet
Financials in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jul '22 Jul 1, 2022 | Jul '21 Jul 1, 2021 | Jun '20 Jun 30, 2020 | 2015 - 2019 |
| Cash & Equivalents | 5.22 | 10.4 | 11.3 | 28.69 | 35.59 | 13.84 | Upgrade
|
| Cash & Short-Term Investments | 5.22 | 10.4 | 11.3 | 28.69 | 35.59 | 13.84 | Upgrade
|
| Cash Growth | -50.14% | -8.04% | -60.60% | -19.38% | 157.17% | -91.38% | Upgrade
|
| Accounts Receivable | 206.48 | 202.26 | 223.65 | 218.93 | 245.75 | 226.08 | Upgrade
|
| Receivables | 206.48 | 202.26 | 223.65 | 218.93 | 245.75 | 226.08 | Upgrade
|
| Inventory | 167.56 | 161.59 | 178.61 | 181.09 | 202.09 | 190.29 | Upgrade
|
| Other Current Assets | 119.44 | 121.69 | 117.63 | 110.18 | 125.23 | 182.25 | Upgrade
|
| Total Current Assets | 498.7 | 495.94 | 531.2 | 538.89 | 608.67 | 612.46 | Upgrade
|
| Property, Plant & Equipment | 1,305 | 1,326 | 1,345 | 1,355 | 1,295 | 1,127 | Upgrade
|
| Total Assets | 1,804 | 1,822 | 1,876 | 1,894 | 1,904 | 1,739 | Upgrade
|
| Accounts Payable | 0.2 | 0.86 | 0.83 | 0.93 | 0.62 | 0.37 | Upgrade
|
| Accrued Expenses | 9.19 | 10.32 | 12.8 | 13.16 | 20.98 | 18.8 | Upgrade
|
| Short-Term Debt | 20 | 24.2 | 43.61 | 75.36 | 84.94 | - | Upgrade
|
| Current Income Taxes Payable | 50.44 | 49.97 | 52.46 | 50.88 | 50.72 | 107.77 | Upgrade
|
| Other Current Liabilities | 14.88 | 14.81 | 15.1 | 13.88 | 13.11 | - | Upgrade
|
| Total Current Liabilities | 94.7 | 100.15 | 124.8 | 154.2 | 170.36 | 126.95 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 147.91 | 141.1 | 129.14 | 114.56 | 108.18 | 94.72 | Upgrade
|
| Other Long-Term Liabilities | -0 | -0 | - | - | - | - | Upgrade
|
| Total Liabilities | 242.62 | 241.26 | 253.95 | 268.76 | 278.54 | 221.67 | Upgrade
|
| Common Stock | 1,162 | 1,162 | 1,162 | 1,162 | 1,137 | 1,115 | Upgrade
|
| Retained Earnings | 399.14 | 418.79 | 459.77 | 462.98 | 488.05 | 402.53 | Upgrade
|
| Shareholders' Equity | 1,561 | 1,581 | 1,622 | 1,625 | 1,625 | 1,518 | Upgrade
|
| Total Liabilities & Equity | 1,804 | 1,822 | 1,876 | 1,894 | 1,904 | 1,739 | Upgrade
|
| Total Debt | 20 | 24.2 | 43.61 | 75.36 | 84.94 | - | Upgrade
|
| Net Cash (Debt) | -14.78 | -13.8 | -32.31 | -46.67 | -49.35 | 13.84 | Upgrade
|
| Net Cash Growth | - | - | - | - | - | -91.38% | Upgrade
|
| Net Cash Per Share | -0.10 | -0.12 | -0.28 | -0.40 | -0.43 | 0.12 | Upgrade
|
| Filing Date Shares Outstanding | 116.21 | 116.21 | 116.21 | 116.21 | 113.74 | 113.67 | Upgrade
|
| Total Common Shares Outstanding | 116.21 | 116.21 | 116.21 | 116.21 | 113.74 | 113.67 | Upgrade
|
| Working Capital | 404 | 395.79 | 406.39 | 384.69 | 438.3 | 485.51 | Upgrade
|
| Book Value Per Share | 13.43 | 13.60 | 13.96 | 13.98 | 14.29 | 13.35 | Upgrade
|
| Tangible Book Value | 1,561 | 1,581 | 1,622 | 1,625 | 1,625 | 1,518 | Upgrade
|
| Tangible Book Value Per Share | 13.43 | 13.60 | 13.96 | 13.98 | 14.29 | 13.35 | Upgrade
|
| Land | - | 160.11 | 160.11 | 162.11 | 93.5 | 91.39 | Upgrade
|
| Buildings | - | 236.17 | 236.17 | 236.17 | 232.92 | 229.89 | Upgrade
|
| Machinery | - | 1,061 | 1,061 | 1,037 | 967.42 | 771.05 | Upgrade
|
| Construction In Progress | - | 39.28 | 29.15 | 23.56 | 66.18 | 65.05 | Upgrade
|
Updated Dec 24, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.